15.30
price up icon2.00%   0.30
pre-market  Pre-mercato:  15.30  
loading

Perché le azioni Myriad Genetics Inc (MYGN) sono in ribasso?

Abbiamo notato un calo di 6.59% nelle azioni di Myriad Genetics Inc (MYGN) durante la sessione di negoziazione di 2024-11-12. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research LH
$237.85
price up icon 0.69%
diagnostics_research WAT
$357.77
price up icon 3.79%
$167.88
price up icon 3.57%
$131.68
price down icon 2.46%
diagnostics_research MTD
$1,166.90
price up icon 0.54%
$418.61
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):